These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 23999725)

  • 1. A macrocyclic peptide that serves as a cocrystallization ligand and inhibits the function of a MATE family transporter.
    Hipolito CJ; Tanaka Y; Katoh T; Nureki O; Suga H
    Molecules; 2013 Aug; 18(9):10514-30. PubMed ID: 23999725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystallographic Analysis of MATE-Type Multidrug Exporter with Its Inhibitors.
    Kusakizako T; Tanaka Y; Hipolito CJ; Suga H; Nureki O
    Methods Mol Biol; 2018; 1700():37-57. PubMed ID: 29177824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural basis for the drug extrusion mechanism by a MATE multidrug transporter.
    Tanaka Y; Hipolito CJ; Maturana AD; Ito K; Kuroda T; Higuchi T; Katoh T; Kato HE; Hattori M; Kumazaki K; Tsukazaki T; Ishitani R; Suga H; Nureki O
    Nature; 2013 Apr; 496(7444):247-51. PubMed ID: 23535598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In Vitro Selected Macrocyclic Peptides: Tools for Regulating the Conformational Freedom of Transmembrane Proteins].
    Hipolito CJ; Nishio K; Suga H
    Yakugaku Zasshi; 2016; 136(2):191-6. PubMed ID: 26831792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The N-terminal domain of an archaeal multidrug and toxin extrusion (MATE) transporter mediates proton coupling required for prokaryotic drug resistance.
    Jagessar KL; Mchaourab HS; Claxton DP
    J Biol Chem; 2019 Aug; 294(34):12807-12814. PubMed ID: 31289123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequence and structural determinants of ligand-dependent alternating access of a MATE transporter.
    Jagessar KL; Claxton DP; Stein RA; Mchaourab HS
    Proc Natl Acad Sci U S A; 2020 Mar; 117(9):4732-4740. PubMed ID: 32075917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Affinity-directed substrate/H
    Takeuchi K; Ueda T; Imai M; Fujisaki M; Shimura M; Tokunaga Y; Kofuku Y; Shimada I
    Structure; 2024 Aug; 32(8):1150-1164.e3. PubMed ID: 38815577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inward-facing conformation of a multidrug resistance MATE family transporter.
    Zakrzewska S; Mehdipour AR; Malviya VN; Nonaka T; Koepke J; Muenke C; Hausner W; Hummer G; Safarian S; Michel H
    Proc Natl Acad Sci U S A; 2019 Jun; 116(25):12275-12284. PubMed ID: 31160466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein cocrystallization molecules originating from in vitro selected macrocyclic peptides.
    Hipolito CJ; Bashiruddin NK; Suga H
    Curr Opin Struct Biol; 2014 Jun; 26():24-31. PubMed ID: 24681557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms for Two-Step Proton Transfer Reactions in the Outward-Facing Form of MATE Transporter.
    Nishima W; Mizukami W; Tanaka Y; Ishitani R; Nureki O; Sugita Y
    Biophys J; 2016 Mar; 110(6):1346-54. PubMed ID: 27028644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insights into conformational regulation of PfMATE transporter from Pyrococcus furiosus induced by alternating protonation state of Asp41 residue: A molecular dynamics simulation study.
    Jin X; Shao Y; Bai Q; Xue W; Liu H; Yao X
    Biochim Biophys Acta; 2016 Jun; 1860(6):1173-80. PubMed ID: 26879959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conserved binding site in the N-lobe of prokaryotic MATE transporters suggests a role for Na
    Castellano S; Claxton DP; Ficici E; Kusakizako T; Stix R; Zhou W; Nureki O; Mchaourab HS; Faraldo-Gómez JD
    J Biol Chem; 2021; 296():100262. PubMed ID: 33837745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Broadly conserved Na
    Ficici E; Zhou W; Castellano S; Faraldo-Gómez JD
    Proc Natl Acad Sci U S A; 2018 Jul; 115(27):E6172-E6181. PubMed ID: 29915058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal structure of Pyrococcus furiosus PF2050, a member of the DUF2666 protein family.
    Han BG; Jeong KC; Cho JW; Jeong BC; Song HK; Lee JY; Shin DH; Lee S; Lee BI
    FEBS Lett; 2012 May; 586(9):1384-8. PubMed ID: 22616997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of an archaeal multidrug transporter with a unique amino acid composition.
    Ninio S; Schuldiner S
    J Biol Chem; 2003 Apr; 278(14):12000-5. PubMed ID: 12551892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure of the
    Ovchinnikov V; Stone TA; Deber CM; Karplus M
    Proc Natl Acad Sci U S A; 2018 Aug; 115(34):E7932-E7941. PubMed ID: 30082384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De Novo Discovery of Pseudo-Natural Prenylated Macrocyclic Peptide Ligands.
    Inoue S; Thanh Nguyen D; Hamada K; Okuma R; Okada C; Okada M; Abe I; Sengoku T; Goto Y; Suga H
    Angew Chem Int Ed Engl; 2024 Sep; 63(36):e202409973. PubMed ID: 38837490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structure of the Lrp-like transcriptional regulator from the archaeon Pyrococcus furiosus.
    Leonard PM; Smits SH; Sedelnikova SE; Brinkman AB; de Vos WM; van der Oost J; Rice DW; Rafferty JB
    EMBO J; 2001 Mar; 20(5):990-7. PubMed ID: 11230123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of essential amino acid residues of the NorM Na+/multidrug antiporter in Vibrio parahaemolyticus.
    Otsuka M; Yasuda M; Morita Y; Otsuka C; Tsuchiya T; Omote H; Moriyama Y
    J Bacteriol; 2005 Mar; 187(5):1552-8. PubMed ID: 15716425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of novel natural inhibitor for NorM - a multidrug and toxic compound extrusion transporter - an insilico molecular modeling and simulation studies.
    Kesherwani M; Michael Gromiha M; Fukui K; Velmurugan D
    J Biomol Struct Dyn; 2017 Jan; 35(1):58-77. PubMed ID: 26786386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.